Samsung Galaxy Watch Study Demonstrates High Accuracy in Predicting Fainting Episodes
A new clinical study conducted by Samsung in collaboration with Chung-Ang University Gwangmyeong Hospital reveals that a modified Samsung Galaxy Watch 6 can predict vasovagal syncope, a condition causing fainting, with high accuracy. The research involved 132 patients and utilized an additional photoplethysmography sensor alongside AI algorithms to monitor heart rate variability. The system successfully predicted fainting episodes within a five-minute window with 84.6% accuracy. This breakthrough aims to provide users with early warnings, allowing them to sit down or seek help, thereby reducing the risk of secondary injuries such as concussions or blood loss from falls. While vasovagal syncope affects up to 40% of people during their lifetime, the fainting itself is rarely life-threatening; however, the resulting falls can cause significant harm. Although the technology shows promise, it remains in the clinical study phase. Samsung has not confirmed plans for immediate commercial release but expressed commitment to health-focused technological innovation. Experts suggest this feature could appear in future wearable devices, potentially transforming preventive healthcare for individuals prone to sudden loss of consciousness.
Wire timeline
Samsung Galaxy Watch Study Demonstrates High Accuracy in Predicting Fainting Episodes
A new clinical study conducted by Samsung in collaboration with Chung-Ang University Gwangmyeong Hospital reveals that a modified Samsung Galaxy Watch 6 can predict vasovagal syncope, a condition causing fainting, with high accuracy. The research involved 132 patients and utilized an additional photoplethysmography sensor alongside AI algorithms to monitor heart rate variability. The system successfully predicted fainting episodes within a five-minute window with 84.6% accuracy. This breakthrough aims to provide users with early warnings, allowing them to sit down or seek help, thereby reducing the risk of secondary injuries such as concussions or blood loss from falls. While vasovagal syncope affects up to 40% of people during their lifetime, the fainting itself is rarely life-threatening; however, the resulting falls can cause significant harm. Although the technology shows promise, it remains in the clinical study phase. Samsung has not confirmed plans for immediate commercial release but expressed commitment to health-focused technological innovation. Experts suggest this feature could appear in future wearable devices, potentially transforming preventive healthcare for individuals prone to sudden loss of consciousness.
PCMag.com - Technology Product Reviews, News, Prices & Tips